Market Summary Follow

NewLink Genetics Corporation is a A biopharmaceutical company

NLNK - Market Data & News

NLNK - Stock Valuation Report

NewLink Genetics Corporation (NLNK) had a rough trading day for Wednesday April 05 as shares tumbled 14%, or a loss of $-2.91 per share, to close at $17.88. After opening the day at $20.79, shares of NewLink Genetics Corporation traded as high as $20.79 and as low as $17.84. Volume was 2.26 million shares over 14,772 trades, against an average daily volume of 371,077 shares and a total float of 29.22 million.

As a result of the decline, NewLink Genetics Corporation now has a market cap of $522.44 million. In the last year, shares of NewLink Genetics Corporation have traded between a range of $25.17 and $9.23, and its 50-day SMA is currently $17.33 and 200-day SMA is $13.09.

For a complete fundamental analysis of NewLink Genetics Corporation, check out Equities.coms Stock Valuation Analysis report for NLNK.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investments Market Commentary and Adam Sarhans Find Leading Stocks today.

NewLink Genetics Corp is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing immunotherapeutic products to improve treatment options for patients with cancer.

NewLink Genetics Corporation is based out of Ames, IA and has some 122 employees. Its CEO is Charles J. Link.

NewLink Genetics Corporation is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on NewLink Genetics Corporation and to follow the companys latest updates, you can visit the companys profile page here: NLNKs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Read more here:
NewLink Genetics Corporation (NLNK) Plunges 14% on April 05 - Equities.com